New hypertension drug candidate tested in healthy people for first time
NCT ID NCT07529600
First seen May 06, 2026 · Last updated May 07, 2026 · Updated 1 time
Summary
This early-stage study tested a single shot of ART101 in 40 healthy adults to check its safety and how the body processes it. Participants received either the drug or a placebo, and researchers monitored for side effects and changes in blood-related markers. The goal was not to treat high blood pressure but to gather essential safety data before testing in patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION (HTN) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Friendship Hospital, Capital Medical University
Beijing, China
-
Suzhou Arnatar Therapeutics Co., Ltd
Suzhou, Jiangsu, China
Conditions
Explore the condition pages connected to this study.